Diseases, Conditions, Syndromes

Pushing the boundaries of treatment for Wilson disease

Uyen To, MD, assistant professor of medicine (digestive diseases) and transplant hepatologist, discusses how she first became interested in studying Wilson disease, the wide spectrum of symptoms caused by the rare condition, ...

Diseases, Conditions, Syndromes

Bacterial agent opens new therapeutic options for Wilson's disease

A specific molecule excreted by methane-oxidizing bacteria could be most suitable for therapy against Wilson's disease (WD). This is what researchers led by Helmholtz Munich scientist Hans Zischka have found in a new study. ...

Oncology & Cancer

Can a second opinion make a difference?

Your doctor may be the smartest, most compassionate, thoughtful person in the world—a leading specialist or someone you've trusted for years. But you shouldn't let that stop you from getting a second opinion.

Diseases, Conditions, Syndromes

Highly efficient agent against Wilson disease

In the Journal of Clinical Investigation, scientists at the Helmholtz Zentrum München describe a small peptide that very efficiently binds excess copper from liver cells. This molecule comes from a bacterium's bag of tricks ...

Wilson's disease or hepatolenticular degeneration is an autosomal recessive genetic disorder in which copper accumulates in tissues; this manifests as neurological or psychiatric symptoms and liver disease. It is treated with medication that reduces copper absorption or removes the excess copper from the body, but occasionally a liver transplant is required.

The condition is due to mutations in the Wilson disease protein (ATP7B) gene. A single abnormal copy of the gene is present in 1 in 100 people, who do not develop any symptoms (they are carriers). If a child inherits the gene from both parents, the child may develop Wilson's disease. Symptoms usually appear between the ages of 6 and 20 years, but cases in much older people have been described. Wilson's disease occurs in 1 to 4 per 100,000 people. Wilson's disease is named after Samuel Alexander Kinnier Wilson (1878–1937), the British neurologist who first described the condition in 1912.

This text uses material from Wikipedia licensed under CC BY-SA